Literature DB >> 9271121

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

S Altiok1, M Xu, B M Spiegelman.   

Abstract

PPAR gamma is an adipose-selective nuclear hormone receptor that plays a key role in the control of adipocyte differentiation. Previous studies indicated that activation of ectopically expressed PPAR gamma induces differentiation when cells have ceased growth because of confluence. We show here that ligand activation of PPAR gamma is sufficient to induce growth arrest in fibroblasts and SV40 large T-antigen transformed, adipogenic HIB1B cells. Cell cycle withdrawal is accompanied by a decrease in the DNA-binding and transcriptional activity of the E2F/DP complex, which is attributable to an increase in the phosphorylation of these proteins, especially DP-1. This effect is a consequence of decreased expression of the catalytic subunit of the serine-threonine phosphatase PP2A. These data suggest an important role for PP2A in the control of E2F/DP activity and a new mode of cell cycle control in differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271121      PMCID: PMC316411          DOI: 10.1101/gad.11.15.1987

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  84 in total

1.  Differential regulation of E2F transactivation by cyclin/cdk2 complexes.

Authors:  B D Dynlacht; O Flores; J A Lees; E Harlow
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

Review 2.  Ordering S phase and M phase in the cell cycle.

Authors:  P Nurse
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

Review 3.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  E2F-4, a new member of the E2F transcription factor family, interacts with p107.

Authors:  D Ginsberg; G Vairo; T Chittenden; Z X Xiao; G Xu; K L Wydner; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

Review 5.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

6.  E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

Authors:  R L Beijersbergen; R M Kerkhoven; L Zhu; L Carlée; P M Voorhoeve; R Bernards
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

7.  Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor.

Authors:  T J Logan; K L Jordan; D Hall
Journal:  Mol Biol Cell       Date:  1994-06       Impact factor: 4.138

8.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

Review 9.  DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control.

Authors:  N B La Thangue
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

10.  Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.

Authors:  S O Freytag; D L Paielli; J D Gilbert
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

View more
  96 in total

1.  Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.

Authors:  S Wang; N Nath; A Minden; S Chellappan
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Opposing roles of pRB and p107 in adipocyte differentiation.

Authors:  M Classon; B K Kennedy; R Mulloy; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.

Authors:  Rebecca L Landsberg; Julia E Sero; Paul S Danielian; Tina L Yuan; Eunice Y Lee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 4.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

Review 5.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

6.  Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function.

Authors:  Shaida Andrabi; Justin H Hwang; Jennifer Kean Choe; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 7.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 8.  The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.

Authors:  Kay F Macleod
Journal:  Nat Rev Cancer       Date:  2008-09-18       Impact factor: 60.716

9.  White fat progenitor cells reside in the adipose vasculature.

Authors:  Wei Tang; Daniel Zeve; Jae Myoung Suh; Darko Bosnakovski; Michael Kyba; Robert E Hammer; Michelle D Tallquist; Jonathan M Graff
Journal:  Science       Date:  2008-09-18       Impact factor: 47.728

10.  Peroxisome proliferator-activated receptor-γ agonist-mediated inhibition of cell growth is independent of apoptosis in human epidermoid carcinoma A431 cells.

Authors:  Qian Li; Yu-Sheng Peng; Ping-Jiao Chen; Meng-Lei Wang; Can Cao; Hao Xiong; Jing Zhang; Ming-Hua Chen; Xue-Biao Peng; Kang Zeng
Journal:  Oncol Lett       Date:  2018-02-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.